US 10806781
Compositions and methods for live, attenuated alphavirus formulations
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 10806781 (Compositions and methods for live, attenuated alphavirus formulations) held by Takeda Vaccines, Inc. expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/5254, A61K39/12, A61K47/22, A61K47/26